Segall Bryant & Hamill LLC Purchases New Shares in Liquidia Corporation $LQDA

Segall Bryant & Hamill LLC purchased a new position in Liquidia Corporation (NASDAQ:LQDAFree Report) in the first quarter, HoldingsChannel.com reports. The institutional investor purchased 55,938 shares of the company’s stock, valued at approximately $2,111,000.

Several other institutional investors and hedge funds also recently bought and sold shares of LQDA. Farallon Capital Management LLC increased its position in Liquidia by 1.1% during the fourth quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock valued at $298,547,000 after acquiring an additional 90,400 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Liquidia by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock worth $138,439,000 after acquiring an additional 52,671 shares during the last quarter. Opaleye Management Inc. boosted its stake in shares of Liquidia by 9.5% during the 2nd quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock worth $30,838,000 after purchasing an additional 215,000 shares during the period. Bank of America Corp DE boosted its stake in shares of Liquidia by 18.7% during the 1st quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after purchasing an additional 360,372 shares during the period. Finally, Caprock Group LLC grew its holdings in Liquidia by 9.3% during the 4th quarter. Caprock Group LLC now owns 1,783,921 shares of the company’s stock valued at $61,527,000 after purchasing an additional 151,832 shares during the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on LQDA. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research report on Friday, July 17th. Stephens set a $130.00 target price on Liquidia in a research report on Friday, July 24th. Zacks Research raised Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Royal Bank Of Canada set a $130.00 price target on Liquidia in a report on Friday, July 24th. Finally, HC Wainwright set a $36.00 price target on Liquidia in a research note on Friday, July 24th. Three research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Liquidia currently has an average rating of “Moderate Buy” and an average price target of $86.18.

Get Our Latest Stock Analysis on LQDA

Liquidia Trading Up 5.4%

NASDAQ LQDA opened at $88.38 on Wednesday. The stock has a market cap of $7.86 billion, a PE ratio of 631.33 and a beta of 0.58. Liquidia Corporation has a 12 month low of $19.02 and a 12 month high of $91.10. The company’s 50-day moving average price is $74.79 and its 200-day moving average price is $52.72. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18.

Liquidia (NASDAQ:LQDAGet Free Report) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. The company had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business’s revenue was up 4187.1% compared to the same quarter last year. Equities research analysts forecast that Liquidia Corporation will post 3.02 earnings per share for the current year.

Insider Buying and Selling

In other Liquidia news, Director Paul B. Manning sold 200,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $63.91, for a total transaction of $12,782,000.00. Following the transaction, the director directly owned 716,311 shares in the company, valued at $45,779,436.01. This trade represents a 21.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Stephen M. Bloch sold 318,893 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $50.23, for a total value of $16,017,995.39. Following the transaction, the director owned 1,870,042 shares in the company, valued at $93,932,209.66. The trade was a 14.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 2,175,754 shares of company stock worth $143,922,108. Corporate insiders own 25.60% of the company’s stock.

About Liquidia

(Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Read More

Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liquidia Corporation (NASDAQ:LQDAFree Report).

Institutional Ownership by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.